PET-CT for Brain Tumours: — Why MRI Usually Comes First

MRI and PET answer different questions. MRI shows anatomy — the size, location, and boundaries of a tumour. PET shows metabolic activity — whether a particular area is actively growing or not. There are situations, such as assessing whether a bright area on MRI is tumour regrowth or radiation damage, where PET provides information that MRI cannot. Your team ordered a PET scan because there is a specific question that MRI alone could not answer. It is entirely reasonable to ask them what that question is.

No. PET measures metabolic activity, not cell type. It can show that an area is highly active or relatively quiet, but it cannot determine whether cells are cancerous or which type of tumour is present. A biopsy is required to confirm the diagnosis. PET may help guide where the biopsy is taken — to the most active region of a large or uneven tumour — but it does not replace histology.

Radiation necrosis is tissue damage caused by radiotherapy — the treated area is dead or dying, not growing. Tumour recurrence means the cancer has started growing again. Both can appear as an enlarging bright area on MRI, which makes them very difficult to distinguish on imaging alone. PET can help by showing whether the area has high metabolic activity, which suggests living tumour, or low activity, which suggests treatment damage. The distinction matters because the management of each is very different.

Yes. The amount of radioactive material used is small and leaves the body within hours. The radiation dose is considered acceptable for diagnostic use by AERB, India's nuclear regulatory body, and is comparable to other standard medical scans. If you are pregnant or breastfeeding, tell your team before the scan is booked — the approach will need to be reviewed. For routine diagnostic use, there are no lasting effects on the brain or the rest of the body.

The full appointment is usually two to three hours. Most of that time is waiting after the tracer is injected — the scanner itself runs for 20 to 40 minutes. You will be asked to rest quietly during the waiting period. Bring something to read and dress comfortably. If you are having an amino acid tracer rather than FDG, your preparation instructions will tell you if the timing differs.

Tell your oncologist or neurosurgeon immediately. Amino acid tracers in particular are not available at every centre, and your team needs to arrange the scan at one that can provide the specific tracer they have requested. Going ahead with a different tracer than specified may mean the scan does not answer the clinical question your team had in mind. Do not substitute without speaking to your team first — travelling further for the right scan is usually the better choice.